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Over the last few years a signifi cant amount of genetic, biochemical, and pharmacological data have indicated that prion disorders are associated with brain cholesterol alterations. 
At the molecular level, growing evidence indicate that the cholesterol–rich domains of plasma 
membrane (i.e. raft s) represent preferred sites of conversion of the cellular prion protein (PrPc) 
into pathogenic prion isoform(s) (PrPsc), and that alterations of membrane cholesterol, the main 
regulator of organization and function of raft  domains, play a key role in prion pathophysiology. 
In this context, our studies showed that brains from mice and sheep infected with scrapie, as well 
as persistently prion-infected mouse neuroblastoma N2a cells, exhibit an increased content of 
cholesterol and an altered ratio of the intracellular cholesterol pools [i.e. free cholesterol (FC) vs. 
cholesterol esters (CE)], resulting in abnormal cytoplasmic accumulation of CE. Interestingly, 
we found that also cells from peripheral tissues [i.e. ex vivo cultures of skin fi broblasts and 
peripheral blood mononuclear cells (PBMCs)] of scrapie-infected sheep, show a similar pattern 
of cholesterol alterations. Th e biochemical cholesterol modifi cations were accompanied by 
changes in the expression levels of genes and gene-products involved in cholesterol esterifi cation 
and traffi  cking [i.e. acyl-coenzymeA:cholesterol-acyltransferase (ACAT-1; up-regulated) and 
caveolin-1 (Cav-1; down-regulated)]. Altogether these data indicate that prion disorders are 
likely associated with major systemic alterations of the cholesterol homeostatic networks. 
In addition, in persistently prion-infected N2a cells, we found that drugs [i.e. everolimus, 
pioglitazone, Sandoz 58035, progesterone, verapamil] able to reduce the CE pool by diff erent 
mechanisms, were also able to inhibit the generation of the PK-resistant prion protein (PrPres) 
in a dose-response manner, and that strong synergistic anti-prion eff ects can be obtained with 
combinations of various cholesterol interfering drugs, apparently via restoration of cholesterol 
homeostasis in the infected cell. Although eff ectiveness of such drug combinations has yet to be 
proved in vivo, the enhanced anti-prion eff ect suggests that a rational design of drug combinations 
which interact at the cholesterol metabolism level, contributing to a better understanding of the 
complex relationship that links cholesterol metabolism to PrPsc biogenesis, may lead to the 
development of novel therapeutic and/or prophylactic approaches for the successful control of 
prion disorders.
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